Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.
Uryu K, Imamura Y, Shimoyama R, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Hibino M, Horiuchi S, Fukui T, Fukai R, Chihara Y, Iwase A, Yamada N, Tamura Y, Harada H, Shinozaki N, Shimada T, Tsuya A, Fukuoka M, Minami H.
Uryu K, et al. Among authors: fukai r.
Cancer Chemother Pharmacol. 2024 Aug;94(2):197-208. doi: 10.1007/s00280-024-04666-4. Epub 2024 Apr 8.
Cancer Chemother Pharmacol. 2024.
PMID: 38584202